The Business Research Company published its Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Pharmaceutical Contract Development And Manufacturing Organization (CMO) market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the Pharmaceutical CMO market’s segments-
By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging.
View Complete Report:
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global pharmaceutical contract development and manufacturing market is expected to decline from $99.8 billion in 2019 to $93 billion in 2020 at a compound annual growth rate (CAGR) of -7%. The decline is mainly due to the focus on COVID-19 outbreak and its treatment across the globe, and disruption in the supply chain owing to geographical trade barriers affecting the supply of APIs and raw materials for drug manufacturing. Sponsors contracting CMOs are pausing the drug development activities due to COVID-19 or restructuring the current drug development plans. The market is then expected to recover and reach $128.4 billion in 2023 at a CAGR of 6.5%.
Companies in the pharmaceutical CMO market are investing towards acquiring and forming alliances with other companies in the market. The pharmaceutical CMO companies are following the trend of merger and acquisition in order to expand their global market reach to meet client needs, to increase their production capabilities while maintaining cost efficiencies and to get access to latest technology and new services. The high level of merger and acquisition activities are resulting in consolidation of the contract service providers.
Few Points From Table Of Content
- Executive Summary
2. Report Structure
3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics
4. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Product Analysis
5. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Supply Chain
……
25. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Market - Pharmaceutical Contract Development And Manufacturing Market Trends And Strategies
- Pharmaceutical Contract Development And Manufacturing Market Future Outlook and Potential Analysis
- Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
……..
Table 25: Recipharm AB Financial Performance
Table 26: Pfizer Inc. Financial Performance
Table 27: Catalent Pharma Solutions Financial Performance
Table 28: Aenova Group Financial Performance
Table 29: Famar Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
The Business Research Company published its Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical CMO market.
The report covers the pharmaceutical CMO market’s segments- by type: active pharmaceutical ingredient (API) manufacturing; finished dosage formulation (FDF) development & manufacturing; secondary packaging.View Complete Report: https://www.thebusinessresearchcompany.com/report/pharmaceutical-contract-development-and-manufacturing-organization-cmo-market-global-report-2020-covid-19-implications-and-growthPharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The companies in the pharmaceutical contract development and manufacturing market are investing towards acquiring and forming alliances with other companies in the market.
